Alnylam Pharmaceuticals
ALNY
#1096
Rank
NZ$38.18 B
Marketcap
NZ$285.07
Share price
1.20%
Change (1 day)
-62.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company